Royal Sense Limited has announced a major business development with the award of a significant tender from the Central Procurement Agency under the Directorate General of Health Services. The tender was awarded to TTG Innovations Private Limited, which is the proposed transferor company set to be merged with Royal Sense Limited following regulatory approvals.

Tender Details and Scope

The contract encompasses the supply of comprehensive surgical sutures used across various medical and surgical procedures. The tender covers multiple suture types to meet diverse healthcare requirements.

Product Specifications

The tender covers a wide range of surgical sutures designed to meet stringent medical standards:

• Absorbable sutures for internal surgical procedures
• Non-absorbable sutures for external applications
• Monofilament sutures for precise surgical work
• Braided sutures for enhanced strength
• Specialty sutures for specific medical requirements

All products must comply with prescribed specifications and quality standards as mandated by the health services department.

Financial Impact and Business Outlook

The company's board has indicated significant revenue potential from this contract award. According to the disclosure, sales may increase by up to ₹100.00 crores through this tender over the contract period.

Corporate Structure Context

This tender award comes as part of ongoing corporate restructuring activities. TTG Innovations Private Limited, the entity that received the tender, is currently undergoing a merger process with Royal Sense Limited. The company has received a No Objection Certificate from BSE Limited for the proposed scheme of arrangement.

The tender represents a significant milestone for the company's healthcare products division, positioning it as a key supplier to government health services. The contract's requirement-based supply model provides flexibility while ensuring steady business flow over the two-year execution period.

Royal Sense Limited (RSL) has taken a significant step forward in its proposed merger with TTG Innovations Private Limited (TIPL). The company recently received a no-adverse observation letter from the BSE Limited, paving the way for the next phase of the merger process.

Key Details of the BSE Observation Letter

• Date of Issuance: November 19, 2025
• Validity Period: Six months from the date of issuance
• Purpose: Enables Royal Sense Limited to file the merger scheme with NCLT
• Conditions: Subject to compliance with 15 specific conditions

Merger Scheme Overview

The proposed merger scheme involves the absorption of TTG Innovations Private Limited (Transferor Company) into Royal Sense Limited (Transferee Company). This corporate action falls under sections 230 to 232 of the Companies Act, 2013, and is subject to various regulatory approvals.

Timeline of Events

Compliance Requirements

The BSE's no-adverse observation letter comes with specific conditions that Royal Sense Limited must adhere to:

1. Disclosure requirements as per regulatory provisions
2. Compliance with 15 specific conditions (details not provided in the available information)

Next Steps

With the BSE's no-adverse observation letter in hand, Royal Sense Limited is now positioned to proceed with filing the merger scheme with the National Company Law Tribunal (NCLT). This marks a crucial milestone in the merger process between Royal Sense Limited and TTG Innovations Private Limited.

The company's management will need to ensure strict compliance with the conditions set forth by the BSE as they move forward with the merger proceedings.

Investors and stakeholders of Royal Sense Limited should keep a close watch on further developments related to this merger, as it may have implications for the company's future operations and market position.